SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 374 filers reported holding SHOCKWAVE MED INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,415,043 | -20.2% | 22,175 | +14.3% | 3.12% | -9.2% |
| Q2 2023 | $5,536,098 | +31.9% | 19,397 | +0.2% | 3.43% | +26.7% |
| Q1 2023 | $4,198,479 | +102.6% | 19,363 | -3.9% | 2.71% | +47.4% |
| Q4 2022 | $2,072,769 | -7.2% | 20,142 | +72.4% | 1.84% | -13.3% |
| Q2 2022 | $2,233,000 | -4.9% | 11,681 | +3.2% | 2.12% | -1.8% |
| Q1 2022 | $2,348,000 | +52.6% | 11,321 | +31.2% | 2.16% | +103.0% |
| Q4 2021 | $1,539,000 | -7.6% | 8,631 | +6.7% | 1.06% | +73.6% |
| Q3 2021 | $1,665,000 | +8.3% | 8,086 | -0.2% | 0.61% | +25.9% |
| Q2 2021 | $1,538,000 | -62.6% | 8,106 | -74.3% | 0.49% | -17.9% |
| Q1 2021 | $4,114,000 | +621.8% | 31,584 | +473.7% | 0.59% | +235.0% |
| Q4 2020 | $570,000 | +86.3% | 5,505 | +36.4% | 0.18% | +43.9% |
| Q3 2020 | $306,000 | +22.9% | 4,035 | -7.7% | 0.12% | -61.2% |
| Q2 2019 | $249,000 | – | 4,370 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
| Matisse Capital | 22,175 | $4,415,043 | 3.12% |
| Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
| APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
| AtonRa Partners | 4,374 | $870,863 | 1.83% |
| Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
| GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
| Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
| Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
| DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |